Our results therefore demonstrated that RPS3 regulated melanoma growth through the modulation of the Ca2+/MICU1 dependent mitochondrial signaling and suggest that RPS3 is a potential therapeutic target for melanoma treatment. This evidence concerns the gene MICU1 and melanoma.